Harmony Biosciences Hldgs reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Harmony Biosciences Hldgs using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-04 | $1.08 | $0.88 | 22.7 % |
| Q2 | 2025-08-05 | $0.92 | $0.89 | 3.37 % |
| Q1 | 2025-05-06 | $1.03 | $0.91 | 13.2 % |
| Q4 | 2025-02-25 | $1.08 | $0.82 | 31.7 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-04 | $239.46M | $225.19M | 6.33 % |
| Q2 | 2025-08-05 | $200.49M | $203.72M | -1.59 % |
| Q1 | 2025-05-06 | $184.73M | $182.27M | 1.35 % |
| Q4 | 2025-02-25 | $201.27M | $201.25M | 0.01 % |
Harmony Biosciences Hldgs (HRMY) is scheduled to report earnings on February 24, 2026. The last reported earnings were for reported on November 4, 2025 for Q3.
The Actual EPS was $1.08, which beat the estimate of $0.88.
The Actual Revenue was $239.5M, which beat the estimate of $225.2M.
Browse earnings estimates, EPS, and revenue on all stocks.